AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Summary
Transcript
Episode notes
Exploring the ramifications of GLP1 drugs in addressing obesity on healthcare costs, productivity, and consumer spending habits. Discussing market implications of new drugs from Pfizer and increased production by Eli Lilly and Novo Nordisk, and how changes in weight could influence various industries and consumer behavior.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode